These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16736695)
21. Tools for rapid preoperative cardiovascular risk assessment. Fox GN; Moawad NS; Music RE J Fam Pract; 2003 Apr; 52(4):313-20. PubMed ID: 12681092 [No Abstract] [Full Text] [Related]
22. U.S. statin guidelines: expensive but not necessarily effective. Barry HC; Hoffman JR Am Fam Physician; 2007 May; 75(10):1453-4, 1456. PubMed ID: 17555139 [No Abstract] [Full Text] [Related]
23. Prevention of cardiovascular disease in patients with rheumatic diseases. Domsic R; Maksimowicz-McKinnon K; Manzi S Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):741-56. PubMed ID: 16979536 [TBL] [Abstract][Full Text] [Related]
24. [The Medical Products Agency's new guidelines for primary prevention of cardiovascular diseases. No help to physicians]. Berglund G Lakartidningen; 2006 Nov 22-28; 103(47):3694-5. PubMed ID: 17212315 [No Abstract] [Full Text] [Related]
25. Cohort profile: the Asia Pacific Cohort Studies Collaboration. Woodward M; Barzi F; Martiniuk A; Fang X; Gu DF; Imai Y; Lam TH; Pan WH; Rodgers A; Suh I; Jee SH; Ueshima H; Huxley R; Int J Epidemiol; 2006 Dec; 35(6):1412-6. PubMed ID: 17060333 [No Abstract] [Full Text] [Related]
27. [New European guidelines on cardiovascular disease prevention in relation to the situation in Poland]. Szostak WB; Cybulska B; Kłosiewicz-Latoszek L; Nowicka G; Szostak-Wegierek D Kardiol Pol; 2004 Dec; 61(12):624-7. PubMed ID: 15815771 [No Abstract] [Full Text] [Related]
28. European guidelines on cardiovascular disease prevention in clinical practice: past, present, and future: a need for joint forces. Cífková R; Mancia G; Kjeldsen SE; Laurent S J Hypertens; 2008 Feb; 26(2):157-60. PubMed ID: 18192823 [No Abstract] [Full Text] [Related]
29. Cardiovascular risk and cardiometabolic protection: role of glitazones. Petrazzi L; Grassi D; Polidoro L; D'Aurelio A; Croce G; Properzi G; Tiberti S; Desideri G; Ferri C J Nephrol; 2008; 21(6):826-35. PubMed ID: 19034866 [TBL] [Abstract][Full Text] [Related]
30. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events. Dennison CR; Hughes S J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796 [No Abstract] [Full Text] [Related]
31. [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies]. Mooe T Lakartidningen; 2006 Sep 20-26; 103(38):2732-6. PubMed ID: 17058766 [No Abstract] [Full Text] [Related]
32. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS). Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC; J Clin Pharmacol; 2009 Aug; 49(8):947-56. PubMed ID: 19602720 [TBL] [Abstract][Full Text] [Related]
35. Implementation of guidelines for the prevention of cardiovascular diseases in Europe: problems and challenges. Is the SCORE prediction system useful, or does it do more harm than good? Gjelsvik B; Brekke M Eur J Gen Pract; 2006; 12(4):146-7. PubMed ID: 17127599 [No Abstract] [Full Text] [Related]
36. [The best of epidemiology and cardiovascular prevention in 2006]. Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566 [TBL] [Abstract][Full Text] [Related]
37. European guidelines on cardiovascular disease prevention. Boysen G Int J Stroke; 2009 Apr; 4(2):71. PubMed ID: 19383045 [No Abstract] [Full Text] [Related]
38. [Italian application of the European practice guidelines for prevention of cardiovascular diseases]. Giampaoli S; Riccio C; Vanuzzo D G Ital Cardiol (Rome); 2008 Jan; 9(1):60-7. PubMed ID: 18383764 [No Abstract] [Full Text] [Related]